Intrasteric inhibition of ATP binding is not required to prevent unregulated autophosphorylation or signaling by the insulin receptor

Molecular and Cellular Biology

Volumn 21, Issue 13, 2001, Pages 4197-4207

  Frankel, M ^a   Ablooglu, A J ^a   Leone, J W ^a   Rusinova, E ^a   Alexander Ross, J B ^a   Heinrikson, R L ^a   Kohanski, R A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; INSULIN; INSULIN RECEPTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; AUTOPHOSPHORYLATION; BINDING SITE; CATALYSIS; CONFORMATIONAL TRANSITION; ENZYME KINETICS; ENZYME REGULATION; PEPTIDE MAPPING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; CELL LINE; CULTURE MEDIA, SERUM-FREE; IMMUNOBLOTTING; INSULIN; KINETICS; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; PROTEIN CONFORMATION; RECEPTOR, INSULIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SPECTROMETRY, FLUORESCENCE;

EID: 0034967558     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.13.4197-4207.2001     Document Type: Article

References (58)

1. Activation of the insulin receptor's kinase domain changes the rate-determining step of substrate phosphoo, lation
2. Insulin and insulin-like growth factor receptors in the nervous system
3. Autophosphoorylation dependent destabilization of the insulin receptor kinase domain: Tryptophan-1175 reports changes in the catalytic cleft
4. Creative functions of instability and oscillations in metabolic systems
5. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation
6. Cis-autophosphorylation of juxtamembrane tyrosines in the insulin receptor kinase domain
7. Partial activation of the insulin receptor kinase domain by juxtamembrane autophosphorylation
8. A tyrosine kinase assay using reverse-phase high-performance liquid chromatography
9. Stat5 is a physiological substrate of the insulin receptor
10. Human insulin receptor mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin
11. Autophosphorylation activates the soluble cytoplasmic domain of the insulin receptor in an intermolecular reaction
12. Crystal structure of cyclin-dependent kinase 2
13. Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity
14. The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling
15. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phos phatase-1B gene
16. The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian central nervous system
17. Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. Kinetic correlation to autophosphorylation of specific sites in the beta subunit
18. Conformational changes in the activation loop of the insulin receptor's kinase domain
19. Structural basis for the autoinhibition of calcium/calmodulin-dependent protein kinase I
20. Investigation of hydrogen bonding and proton transfer of aromatic alcohols in nonaqueous solvents by steady-state and time-resolved fluorescence
21. Oscillatory phenomena in biochemistry
22. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
23. Insights into autoregulation from the crystal structure of twitchin kinase
24. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog
25. Autoregulatory mechanisms in protein-tyrosine kinases
26. Crystal structure of the tyrosine kinase domain of the human insulin receptor
27. Analysis of insulin receptor phosphorylation sites in intact rat liver cells by two-dimensional phosphopeptide mapping. Predominance of the tris-phosphorylated form of the kinase domain after stimulation by insulin
28. The eleventh Datta lecture. The structural basis for substrate recognition and control by protein kinases
29. Active and inactive protein kinases: Structural basis for regulation
30. Dealing with energy demand: The AMP-activated protein kinase
31. Intrasteric regulation of protein kinases
32. Insulin receptor autophosphorylation, I. Autophosphorylation kinetics of the native receptor and its cytoplasmic kinase domain
33. Insulin dependent phosphorylation of the insulin receptor protein kinase and activation of glucose transport in 3T3-L1 adipocytes
34. Control of insulin receptor autophosphorylation by polypeptide substrates: Inhibition and stimulation by interaction with the catalytic subunit
35. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
36. Posttranslational processing of the insulin proreceptor
37. Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of lysozyme by iodide ion
38. Evidence that insulin plus ATP may induce a conformational change in the beta subunit of the insulin receptor without inducing receptor autophosphorylation
39. ATP sensitizes the insulin receptor to insulin
40. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B
41. A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein, v-Fps
42. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav
43. Requirement for an additional divalent metal cation to activate protein tyrosine kinases
44. Studies on the autophosphorylation of the insulin receptor from human placenta. Analysis of the sites phosphorylated by two-dimensional peptide mapping
45. Crystallographic and solution studies of an activation loop mutant of the insulin receptor tyrosine kinase. Insights into kinase mechanism
46. Relationship of site-specific β-subunit tyrosine autophosphorylation to insulin activation of the insulin receptor (tyrosine) protein kinase activity
47. Identification of the insulin receptor tyrosine residues undergoing insulin-stimulated phosphorylation in intact rat hepatoma cells
48. Signal transduction by receptors with tyrosine kinase activity
49. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites
50. Cellular basis of direct insulin action in the central nervous system
51. Another version of the human insulin receptor kinase domain: Expression, purification, and characterization
52. Amino acid residues which distinguish the mitogenic potentials of two FGF receptors
53. Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain
54. High-level expression of human insulin receptor cDNA in mouse NIH 3T3 cells
55. 2 heterotetrameric state
56. The regulatory role of known tyrosine autophosphorylation sites of the insulin receptor kinase domain. An assessment by replacement with neutral and negatively charged amino acids